Inhaled colistin has been widely used for years 8, but it is not formally approved by the FDA, and clinicians have also tried various intravenous antibiotics off-label via the nebulized route in ...

In the light of these findings, and because colistin has good in vitro activity and is generally well tolerated, inhaled colistin merits further assessment for use in the treatment of nosocomial ...

The PROMIS program, involving more than 800 patients, is evaluating the inhaled antibiotic, colistin, delivered by a hand-held breath-actuated nebulizer to reduce the frequency of pulmonary ...

A typical amphotericin B regimen is 25 mg every 24 hours. Nebulized colistin is being studied in the prevention and treatment of gram-negative infections and in patients awaiting lung transplants.